Mercer Global Advisors Inc Amgen Inc Transaction History

Mercer Global Advisors Inc

$43 Billion
Q1 2025

A detailed history of Mercer Global Advisors Inc transactions in Amgen Inc stock. As of the latest transaction made, Mercer Global Advisors Inc holds 120,436 shares of AMGN stock, worth $33.5 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

120,436

Previous 116,537 3.35%

Holding current value

$33.5 Million

Previous $30.4 Million 23.53%

% of portfolio

0.09%

Previous 0.07%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$258.59 - $327.36 $1.01 Million - $1.28 Million	3,899 Added 3.35%	120,436 $37.5 Million
Q4 2024 Feb 14, 2025	BUY	$258.78 - $328.31 $30.2 Million - $38.3 Million	116,537 New	116,537 $30.4 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $37.6 Million - $42.5 Million	147,181 Added 154.77%	242,275 $69.8 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $522,792 - $649,060	2,391 Added 2.58%	95,094 $25.6 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $1.45 Million - $1.72 Million	6,772 Added 7.88%	92,703 $20.6 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $1.11 Million - $1.36 Million	4,933 Added 6.09%	85,931 $20.8 Million
Q4 2022 Feb 08, 2023	BUY	$229.03 - $291.01 $844,433 - $1.07 Million	3,687 Added 4.77%	80,998 $21.3 Million
Q3 2022 Nov 15, 2022	BUY	$224.46 - $253.15 $1.31 Million - $1.48 Million	5,843 Added 8.18%	77,311 $17.4 Million
Q2 2022 Aug 10, 2022	BUY	$230.71 - $256.74 $2.12 Million - $2.36 Million	9,208 Added 14.79%	71,468 $17.4 Million
Q1 2022 May 10, 2022	BUY	$219.27 - $242.57 $1.62 Million - $1.79 Million	7,379 Added 13.45%	62,260 $15.1 Million
Q4 2021 Feb 04, 2022	SELL	$198.88 - $227.6 $1.34 Million - $1.53 Million	-6,714 Reduced 10.9%	54,881 $12.3 Million
Q3 2021 Nov 10, 2021	BUY	$212.27 - $248.7 $1.88 Million - $2.21 Million	8,868 Added 16.82%	61,595 $13.1 Million
Q2 2021 Aug 10, 2021	SELL	$233.58 - $259.14 $942,728 - $1.05 Million	-4,036 Reduced 7.11%	52,727 $12.9 Million
Q1 2021 Aug 10, 2021	BUY	$221.91 - $258.6 $1.01 Million - $1.18 Million	4,572 Added 8.76%	56,763 $14.1 Million
Q1 2021 May 11, 2021	BUY	$221.91 - $258.6 $1 Million - $1.17 Million	4,519 Added 9.48%	52,191 $13 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $371,308 - $442,161	1,716 Added 3.73%	47,672 $11 Million
Q3 2020 Dec 10, 2020	BUY	$234.65 - $260.95 $293,312 - $326,187	1,250 Added 2.8%	45,956 $11.7 Million
Q2 2020 Aug 10, 2020	BUY	$197.81 - $242.74 $537,449 - $659,524	2,717 Added 6.47%	44,706 $10.5 Million
Q1 2020 May 18, 2020	BUY	$182.24 - $241.7 $798,757 - $1.06 Million	4,383 Added 11.66%	41,989 $8.51 Million
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $1.53 Million - $1.97 Million	8,100 Added 27.45%	37,606 $9.07 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $1.67 Million - $2 Million	9,605 Added 48.26%	29,506 $5.71 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $95,852 - $112,360	575 Added 2.98%	19,901 $3.67 Million
Q1 2019 Apr 23, 2019	BUY	$180.87 - $203.88 $820,426 - $924,799	4,536 Added 30.67%	19,326 $3.67 Million
Q1 2019 Apr 12, 2019	BUY	$180.87 - $203.88 $2.68 Million - $3.02 Million	14,790 New	14,790 $2.88 Million

Others Institutions Holding AMGN

# of Institutions

3,309

Shares Held

429M

Call Options Held

8.06M

Put Options Held

7.7M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Account

Mercer Global Advisors Inc Amgen Inc Transaction History